We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ADOC market cap is 126.81M. The company's latest EPS is EUR -1.5019 and P/E is -5.99.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 8.14M | 6.83M | 6.06M | 28.56M | 6.05M |
| Operating Income | -22.02M | -21.15M | -19.22M | -1.68M | -14.23M |
| Net Income | -18.6M | -23.32M | -22.75M | -6.9M | -21.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 61.95M | 45.17M | 30.05M | 30.61M | 24.96M |
| Total Liabilities | 33.91M | 38.83M | 43.87M | 43.58M | 31.87M |
| Total Equity | 28.04M | 6.33M | -13.82M | -12.97M | -6.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -9.66M | -21.85M | -19.24M | -15M | -4.95M |
| Investing | -2.05M | -205k | -361k | 21.86M | -138k |
| Financing | 15.53M | 6.51M | 6.65M | -4.61M | 627k |
| Market Cap | 126.81M |
| Price to Earnings Ratio | -5.99 |
| Price to Sales Ratio | 20.96 |
| Price to Cash Ratio | 9.78 |
| Price to Book Ratio | -18.34 |
| Dividend Yield | - |
| Shares Outstanding | 14.09M |
| Average Volume (1 week) | 64.73k |
| Average Volume (1 Month) | 73.27k |
| 52 Week Change | 125.00% |
| 52 Week High | 16.16 |
| 52 Week Low | 3.59 |
| Spread (Intraday) | 0.18 (2%) |
| Company Name | Adocia |
| Address |
115 avenue lacassagne lyon, rhone 69003 |
| Website | https://www.adocia.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
